Home > Financial Ratios > WINDLAS BIOTECH

WINDLAS BIOTECH
Fixed Capital/Sales

    Back to All Ratios
WINDLAS BIOTECH is part of below Screeners ↓
Best 1M Momentum Small Cap Stocks
AD     Remove this Ad

WINDLAS BIOTECH Last 5 Year Fixed Capital/Sales History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Fixed Capital/Sales(x) 0.410.370.350.370.31

What is the latest Fixed Capital/Sales ratio of WINDLAS BIOTECH ?

The latest Fixed Capital/Sales ratio of WINDLAS BIOTECH is 0.41 based on Mar2025 Consolidated results.
Year Fixed Capital/Sales
Mar20250.41
Mar20240.37
Mar20230.35
Mar20220.37
Mar20210.31

How is Fixed Capital/Sales of WINDLAS BIOTECH Trending?

Years Fixed Capital/Sales % Change
Mar2025 0.41
10.81
Mar2024 0.37
5.71
Mar2023 0.35
-5.41
Mar2022 0.37
19.35
Mar2021 0.31 -

Other Financial Ratios of WINDLAS BIOTECH


Compare Fixed Capital/Sales ratio of peers of WINDLAS BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
WINDLAS BIOTECH ₹1,715.2 Cr 5.8% 7.4% -18.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹396,370.0 Cr -3.9% -8.9% -3.2% Stock Analytics
DIVIS LABORATORIES ₹161,193.0 Cr 3.8% -4.7% 11.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹141,438.0 Cr 3.2% -5.6% 26.6% Stock Analytics
DR REDDYS LABORATORIES ₹103,097.0 Cr 3.3% -6% 11% Stock Analytics
CIPLA ₹97,846.7 Cr 0.8% -9.1% -13.1% Stock Analytics


WINDLAS BIOTECH Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
WINDLAS BIOTECH

5.8%

7.4%

-18.7%

SENSEX

3.7%

-0.9%

0.7%


You may also like the below Video Courses